• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[红细胞多胺(EPA)在前列腺腺癌(PA)中的诊断价值:关于100例患者]

[The diagnostic value of erythrocyte polyamines (EPA) in prostatic adenocarcinoma (PA): apropos of 100 patients].

作者信息

Cipolla B, Guille F, Quemener V, Lévêque J M, Moulinoux J P, Lobel B

机构信息

Service d'Urologie, Universitaire de Rennes.

出版信息

Prog Urol. 1992 Feb;2(1):50-7.

PMID:1284385
Abstract

Spermidine and spermine are ubiquitous polyamines which are intensely metabolised in the prostate. Polyamines are involved in the processes of proliferation and differentiation of normal and neoplastic cells. As the erythrocyte levels of these polyamines are correlated with the intratumoral levels, we assayed EPA in 45 controls, 66 patients with benign prostatic hypertrophy and 100 patients with prostatic cancer. Erythrocytic polyamines are markers of proliferation and prostatic metastases and can be used to distinguish between hormone-sensitive and hormone-resistant patients. Although non-specific, polyamines constitute circulating markers of the state of tumour proliferation of a given patient and definitely have a prognostic value which needs to be evaluated by further studies.

摘要

亚精胺和精胺是普遍存在的多胺,在前列腺中被强烈代谢。多胺参与正常细胞和肿瘤细胞的增殖与分化过程。由于这些多胺的红细胞水平与肿瘤内水平相关,我们检测了45名对照者、66名良性前列腺增生患者和100名前列腺癌患者的红细胞多胺(EPA)。红细胞多胺是增殖和前列腺转移的标志物,可用于区分激素敏感型和激素抵抗型患者。尽管多胺是非特异性的,但它们构成了特定患者肿瘤增殖状态的循环标志物,并且肯定具有预后价值,需要进一步研究来评估。

相似文献

1
[The diagnostic value of erythrocyte polyamines (EPA) in prostatic adenocarcinoma (PA): apropos of 100 patients].[红细胞多胺(EPA)在前列腺腺癌(PA)中的诊断价值:关于100例患者]
Prog Urol. 1992 Feb;2(1):50-7.
2
Pretherapeutic erythrocyte polyamine spermine levels discriminate high risk relapsing patients with M1 prostate carcinoma.治疗前红细胞多胺精胺水平可区分M1期前列腺癌高风险复发患者。
Cancer. 1996 Sep 1;78(5):1055-65. doi: 10.1002/(SICI)1097-0142(19960901)78:5<1055::AID-CNCR16>3.0.CO;2-1.
3
Erythrocyte polyamine levels in human prostatic carcinoma.人类前列腺癌中的红细胞多胺水平
J Urol. 1990 Nov;144(5):1164-6. doi: 10.1016/s0022-5347(17)39682-9.
4
[Prostatic specific antigen and prostatic pathology. Value of preoperative blood assay. Preliminary study apropos of 709 case reports].[前列腺特异性抗原与前列腺病理学。术前血液检测的价值。关于709例病例报告的初步研究]
Ann Urol (Paris). 1989;23(4):295-300.
5
Determination of erythrocyte polyamines as a predictive method in tumour diagnosis. An animal study with chemically induced tumours.测定红细胞多胺作为肿瘤诊断的一种预测方法。一项关于化学诱导肿瘤的动物研究。
Anticancer Res. 1995 Nov-Dec;15(6B):2517-22.
6
[Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].[前列腺癌中的前列腺酸性磷酸酶(PAP)、γ-精浆蛋白(γ-Sm)和前列腺特异性抗原(PA)]
Hinyokika Kiyo. 1988 Aug;34(8):1389-96.
7
Erythrocyte polyamines and prognosis in colorectal cancer patients.
Anticancer Res. 2000 May-Jun;20(3B):2113-7.
8
Polyamines and prostatic carcinoma: clinical and therapeutic implications.多胺与前列腺癌:临床及治疗意义
Eur Urol. 1993;24(1):124-31. doi: 10.1159/000474279.
9
[Prostatic diseases: tumor markers (PAP and PSA) and age at risk].[前列腺疾病:肿瘤标志物(前列腺酸性磷酸酶和前列腺特异抗原)及风险年龄]
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):91.
10
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.胰岛素样生长因子-II血清水平提高了前列腺增生与前列腺癌之间的鉴别能力,并改善了前列腺特异性抗原在临床分期中的预测价值。
Eur Urol. 2006 Feb;49(2):286-92; discussion 292. doi: 10.1016/j.eururo.2005.08.022. Epub 2005 Dec 7.